Latest Risk Factors News

News Corporation’s Murdoch Family Trust is selling 14.2 million Class B shares in a significant secondary offering, marking a pivotal step in a broader ownership restructuring that reshapes voting control and family interests.

Bayan Mining and Minerals Limited has launched a pro-rata non-renounceable entitlement offer of Loyalty Options to existing shareholders, aiming to raise $33,319 initially with potential future capital of $2.5 million if options are exercised. The offer highlights shareholder rewards alongside significant risks including dilution and geopolitical factors.

Ariana Resources plc is set to raise up to A$15 million through a dual listing on the ASX, aiming to accelerate development at its flagship Dokwe Gold Project in Zimbabwe and repay existing debt. The capital raising also supports ongoing operations and exploration across its diverse portfolio in Türkiye, Kosovo, and Cyprus.

Tasmea Limited has launched a $43 million institutional placement to strengthen its balance sheet for future acquisitions, following a robust FY25 with significant profit growth and margin expansion. The company’s FY26 guidance signals continued momentum driven by organic growth and strategic acquisitions.

Proteomics International has unveiled new clinical data confirming its PromarkerEso blood test can accurately detect early stages of esophageal adenocarcinoma, potentially transforming screening for a cancer with poor prognosis.

Duxton Farms proposes a scheme of arrangement to acquire all preference shares of Duxton Orchards, offering scrip with optional cash consideration. An independent expert values the transaction as fair and reasonable, highlighting the strategic benefits of a larger, diversified agricultural platform.

Prospech Limited has announced a pro-rata renounceable entitlement offer aiming to raise up to $1.62 million to fund metallurgical testing and exploration at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, reflecting the company’s ongoing development efforts and funding needs.

Excelsior Capital Limited reports a sharp 98% drop in profit after tax for FY25 following the prior year’s $47.2 million gain from selling its CMI Electrical subsidiary. Despite this, the company declared a fully franked final dividend of 4.0 cents per share.

Rhythm Biosciences has formalised a strategic co-marketing partnership with the Know Your Lemons Foundation to promote its geneType Breast Cancer Risk Assessment Test, expanding access to early detection tools for women in the US and Australia.

Lynas Rare Earths has launched a fully underwritten A$750 million equity raising to fund its ambitious Towards 2030 growth strategy, aiming to expand rare earths production and downstream capabilities outside China.

BPH Energy Limited reported a 49% increase in net profit for FY2025, driven by gains in its energy and biotech investments, while facing a pivotal Federal Court hearing over the renewal of the PEP-11 offshore gas exploration permit.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.